From Rare Data to Real Impact Translating Real World Evidence Into Clinical Decisions in Rare Disease

• Translating real world evidence into clinically meaningful insights in rare disease settings where data is limited and uncertainty is high
• Bridging real world evidence and medical affairs to ensure evidence is understood trusted and applied by clinicians and stakeholders globally
• Overcoming challenges of small populations fragmented datasets and lack of standardized endpoints to ensure evidence influences real world treatment decisions

Speakers:

Carmine Colavecchia

Senior Director & Real-World Evidence Scientist

Argenx